Krebs Biochemicals & Industries Limited
NSE: KREBSBIO BSE: KREBSBIO
NSE
59.94
2.04 (3.52%)
Prev Close
57.9
Open Price
59.98
Volume
4,091
Today Low / High
57.69 / 59.98
52 WK Low / High
53.05 / 113.5
Range
57 - 63
BSE
60.00
2.39 (4.15%)
Prev Close
57.61
Open Price
62
Volume
49
Today Low / High
57.07 / 62
52 WK Low / High
51 / 113.9
Range
57 - 63
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 59.94 (target range: 57 - 63), reflecting a change of 2.04 (3.52332%). On the BSE, it is listed at 60 (target range: 57 - 63), showing a change of 2.39 (4.14859%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
25 Feb
59.98
-1.65%
24 Feb
60.00
-3.50%
23 Feb
58.00
0.93%
20 Feb
59.00
-0.68%
19 Feb
59.12
1.15%
18 Feb
58.91
0.98%
17 Feb
57.31
3.30%
16 Feb
61.00
-6.11%
13 Feb
59.83
0.00%
12 Feb
56.10
4.51%
11 Feb
56.50
1.38%
10 Feb
56.60
0.71%
09 Feb
57.13
-0.96%
06 Feb
58.78
-2.33%
05 Feb
59.90
-1.89%
04 Feb
58.10
-0.76%
03 Feb
56.60
2.49%
02 Feb
59.78
-5.37%
01 Feb
58.82
-3.64%
30 Jan
60.50
-2.78%
29 Jan
58.50
4.02%
28 Jan
56.93
2.69%
Krebs Biochemicals & Industries Limited Graph
Krebs Biochemicals & Industries Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Krebs Biochemicals & Industries Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 59.94, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 60.00 | 60.60 | 54.54 - 66.66 |
| 61.20 | 48.96 - 73.44 | ||
| 61.80 | 43.26 - 80.34 | ||
| Bearish Scenario | 60.00 | 59.40 | 53.46 - 65.34 |
| 58.80 | 47.04 - 70.56 | ||
| 58.20 | 40.74 - 75.66 |
Overview of Krebs Biochemicals & Industries Limited
ISIN
INE268B01013
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
12,492
Market Cap
1,292,341,525
Last Dividend
0
Official Website
IPO Date
2016-10-27
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of KREBSBIO
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2005-09-14 | September 14, 05 | 2.89781 | 3 | 2005-09-16 | 2005-10-01 | 2005-06-09 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 43.31 Cr | 5.56 Cr | 37.76 Cr | 0.8717 | 1.52 Cr | 0.00 Cr | -21.72 Cr | -26.94 Cr | -12.50 | -14.32 Cr | -0.6220 |
| 2024-03-31 | 50.42 Cr | 61.30 Cr | -10.87 Cr | -0.2157 | 0.00 Cr | 0.60 Cr | -15.49 Cr | -19.73 Cr | -9.15 | -8.27 Cr | -0.3913 |
| 2023-03-31 | 52.13 Cr | 27.72 Cr | 24.42 Cr | 0.4684 | 0.00 Cr | 0.86 Cr | -21.94 Cr | -24.69 Cr | -11.45 | -15.16 Cr | -0.4736 |
| 2022-03-31 | 59.70 Cr | 65.47 Cr | -5.76 Cr | -0.0965 | 1.64 Cr | 1.14 Cr | -39.49 Cr | -44.53 Cr | -20.65 | -32.85 Cr | -0.7458 |
| 2021-03-31 | 38.61 Cr | 52.23 Cr | -13.63 Cr | -0.3529 | 1.47 Cr | 0.67 Cr | -23.67 Cr | -28.36 Cr | -14.45 | -16.96 Cr | -0.7346 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.14 Cr | 169.04 Cr | 315.27 Cr | -146.2388 Cr | 212.21 Cr | 212.07 Cr | 6.03 Cr | 146.47 Cr | 0.00 Cr | 0.00 Cr | 2.85 Cr | 103.5260 Cr |
| 2024-03-31 | 0.14 Cr | 178.17 Cr | 297.39 Cr | -119.2167 Cr | 238.68 Cr | 238.61 Cr | 10.24 Cr | 149.74 Cr | 0.00 Cr | 0.00 Cr | -0.47 Cr | 61.8339 Cr |
| 2023-03-31 | 0.09 Cr | 174.98 Cr | 274.44 Cr | -99.4623 Cr | 183.24 Cr | 183.15 Cr | 12.36 Cr | 149.05 Cr | 0.00 Cr | 0.00 Cr | 2.09 Cr | 49.1047 Cr |
| 2022-03-31 | 0.03 Cr | 189.81 Cr | 264.90 Cr | -75.0932 Cr | 188.10 Cr | 188.07 Cr | 25.86 Cr | 144.93 Cr | 0.00 Cr | 0.00 Cr | 0.04 Cr | 78.0640 Cr |
| 2021-03-31 | 0.71 Cr | 159.22 Cr | 201.95 Cr | -42.7329 Cr | 111.14 Cr | 125.55 Cr | 16.89 Cr | 128.21 Cr | 0.00 Cr | 0.00 Cr | 0.04 Cr | 48.1924 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -7.8910 Cr | -4.9696 Cr | 12.8648 Cr | -11.4542 Cr | 0.0042 Cr | 0.1416 Cr | -3.5632 Cr | -26.9240 Cr | 18.7789 Cr | 0.0000 Cr | 3.7649 Cr |
| 2024-03-31 | 2.3040 Cr | -7.8167 Cr | 5.5641 Cr | -7.0501 Cr | 0.0516 Cr | 0.1374 Cr | -9.4150 Cr | -19.7284 Cr | 10.2535 Cr | 0.0000 Cr | 2.1492 Cr |
| 2023-03-31 | -24.7132 Cr | -12.6450 Cr | 37.3433 Cr | -35.5836 Cr | -0.0148 Cr | 0.0858 Cr | -10.8704 Cr | -24.6919 Cr | 40.3165 Cr | 0.0000 Cr | 13.6170 Cr |
| 2022-03-31 | -17.2162 Cr | -22.8995 Cr | 39.5056 Cr | -40.7363 Cr | -0.6101 Cr | 0.1006 Cr | -23.5201 Cr | -44.5268 Cr | 32.3835 Cr | 0.0000 Cr | -8.9622 Cr |
| 2021-03-31 | -14.5748 Cr | -22.5493 Cr | 37.6605 Cr | -40.0812 Cr | 0.5364 Cr | 0.7107 Cr | -25.5064 Cr | -28.3586 Cr | 33.4906 Cr | 0.0000 Cr | -1.6049 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 7.27 Cr | 0.00 Cr | 7.27 Cr | 0.9998 | -1.34 Cr | -3.13 Cr | -1.45 | 0.30 Cr | -0.4298 |
| 2025-09-30 | 4.17 Cr | 4.32 Cr | -0.15 Cr | -0.0356 | -4.42 Cr | -6.14 Cr | -2.85 | -2.79 Cr | -1.4740 |
| 2025-06-30 | 5.48 Cr | 0.29 Cr | 5.19 Cr | 0.9472 | -3.69 Cr | -5.32 Cr | -2.47 | -2.08 Cr | -0.9714 |
| 2025-03-31 | 6.10 Cr | 0.57 Cr | 5.53 Cr | 0.9071 | -6.98 Cr | -8.27 Cr | -3.84 | -5.07 Cr | -1.3554 |
| 2024-12-31 | 11.47 Cr | 1.31 Cr | 10.16 Cr | 0.8858 | -6.43 Cr | -7.74 Cr | -3.59 | -4.46 Cr | -0.6749 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 0.15 Cr | 0.00 Cr | 0.15 Cr | 0.05 Cr | 5.77 Cr | 9.78 Cr | 143.54 Cr | 165.91 Cr | 326.75 Cr |
| 2025-09-30 | 0.13 Cr | 0.03 Cr | 0.13 Cr | 0.14 Cr | 5.77 Cr | 10.17 Cr | 145.39 Cr | 168.03 Cr | 325.74 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 0.14 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 146.24 Cr |
| 2025-03-31 | 0.14 Cr | 0.20 Cr | 0.34 Cr | 0.05 Cr | 6.03 Cr | 10.26 Cr | 146.47 Cr | 169.04 Cr | 315.27 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.14 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 130.15 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | -5.32 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | -8.27 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | -7.74 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -5.76 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -5.17 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2019-01-31 | January 31, 19 | 207:200 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,763.30 | ₹4,230,747,352,601.00 | ₹1,200,917.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,387.50 | ₹1,695,680,554,750.00 | ₹348,445.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,435.00 | ₹1,501,005,526,400.00 | ₹360,000.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,305.00 | ₹1,086,501,487,950.00 | ₹2,296,188.00 |
| Lupin Limited | LUPIN | ₹2,293.00 | ₹1,047,999,599,000.00 | ₹1,104,217.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹918.70 | ₹924,427,166,613.00 | ₹564,622.00 |
| Mankind Pharma Limited | MANKIND | ₹2,165.00 | ₹893,722,980,880.00 | ₹802,350.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,215.20 | ₹705,790,132,270.00 | ₹3,039,195.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,646.00 | ₹675,063,990,000.00 | ₹231,441.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,078.50 | ₹586,554,381,507.00 | ₹455,455.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,075.00 | ₹580,345,825,650.00 | ₹2,096,375.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,523.30 | ₹386,467,635,279.00 | ₹102,381.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹3,019.50 | ₹377,243,116,668.00 | ₹185,673.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,087.90 | ₹335,165,447,241.00 | ₹172,357.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,425.00 | ₹270,140,869,500.00 | ₹90,094.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,387.00 | ₹225,376,638,403.00 | ₹212,895.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,889.00 | ₹222,225,000,000.00 | ₹2,581.00 |
| Eris Lifesciences Limited | ERIS | ₹1,380.40 | ₹188,033,796,336.00 | ₹30,282.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹976.20 | ₹174,847,055,094.00 | ₹5,721,410.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,366.00 | ₹171,484,296,374.00 | ₹27,191.00 |
| Granules India Limited | GRANULES | ₹599.95 | ₹145,589,096,164.00 | ₹775,189.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹736.90 | ₹144,847,366,076.00 | ₹143,344.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹906.00 | ₹143,482,991,688.00 | ₹305,240.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,729.00 | ₹131,424,222,384.00 | ₹21,588.00 |
| Cohance Lifesciences Limited | COHANCE | ₹308.75 | ₹118,117,604,475.00 | ₹467,933.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹912.30 | ₹111,972,052,800.00 | ₹41,727.00 |
| Viyash Scientific Limited | VIYASH | ₹220.00 | ₹95,965,222,980.00 | ₹684,579.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,130.00 | ₹85,154,829,660.00 | ₹7,924.00 |
| Strides Pharma Science Limited | STAR | ₹860.15 | ₹79,282,359,947.00 | ₹85,838.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹479.00 | ₹73,335,885,782.00 | ₹136,599.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹708.95 | ₹64,264,396,246.00 | ₹171,834.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹328.00 | ₹64,150,835,648.00 | ₹194,469.00 |
| FDC Limited | FDC | ₹365.80 | ₹59,555,928,727.00 | ₹46,681.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹129.38 | ₹41,986,603,055.00 | ₹619,352.00 |
| Innova Captab Limited | INNOVACAP | ₹668.00 | ₹38,226,252,572.00 | ₹12,206.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹318.90 | ₹34,749,023,009.00 | ₹32,184.00 |
| Suven Life Sciences Limited | SUVEN | ₹150.24 | ₹34,175,693,760.00 | ₹112,596.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹370.50 | ₹33,815,535,000.00 | ₹60,674.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹635.60 | ₹32,237,063,138.00 | ₹129,617.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,897.80 | ₹31,387,742,667.00 | ₹9,696.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹279.00 | ₹27,978,819,174.00 | ₹39,130.00 |
Key Executives
MD, Chief Executive Officer & Director
Manish Kumar Jain
Gender: male
Year Born: 1976
Company Secretary & Compliance Officer
Rakesh Kalbate
Gender: male
Year Born:
Chief Financial Officer
Ritesh Jain
Gender: male
Year Born:
FAQs about Krebs Biochemicals & Industries Limited
Who is the CEO of the company?
The CEO is Manish Kumar Jain.
What is the current market price of the stock?
The current price is ₹59.94.
What is the 52-week price range?
The range is ₹53.05-113.5.
What is the market capitalization of the company?
The market capitalization is ₹129.23 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -5.65.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Krebs Biochemicals & Industries Limited (ISIN: INE268B01013) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹129.23 crores and an average daily volume of 12,492 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.